CD24 polymorphisms cannot predict pathologic complete response to anthracycline- and taxane-based neoadjuvant chemotherapy in breast cancer.
Clinical breast cancer 2014 Apr 14 (2): e33-40.
CD24 and APC Genetic Polymorphisms in Pancreatic Cancers as Potential Biomarkers for Clinical Outcome.
PloS one 0 10 (9): e0134469.
Shamai Sivan, Nabiochtchikov Ilana, Kraus Sarah, Zigdon Sally, Kazanov Dina, Itzhak-Klutch Michal, Eizner Carmit, Arber Nadir, Geva Rav